Recursion Pharmaceuticals Inc (RXRX) Stock Price, Quote, News & History

RXRXNASDAQ
$3.61
-0.18-4.75%
At close: Jun 2, 5:00 PM EST
$3.61
N/A
After Hours: 5:42 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-320.95M
Investing Cash Flow (TTM)
-9.94M
Financing Cash Flow (TTM)
477.54M
Free Cash Flow (TTM)
-328.09M
Capital Expenditure (TTM)
-7.13M
Net Change in Cash (TTM)
146.64M

Analyst Trends and Forecast

1
Dec 25
1
1
Feb
1
Apr
1
1
May
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.1
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$1.43B
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
27.62
PB Ratio (TTM)
1.96
Earnings Yield % (TTM)
-30.61%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$1.93

Company Debt

Total Debt
$16.45M
LT Debt
$7.18M
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$8.59M
Total Cash
$654.47M
Debt to Equity
0.07
Issuance of Debt (TTM)
-$8.59M
Repayment of Debt (TTM)
-$8.59M

Key Statistics

Open
$3.68
Close
$3.61
Volume / Avg.
20.72M / 14.28M
Day Range
$3.57 - $3.79
52 Wk Range
2.77 - 7.18
Market Cap
$1.92B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
60
Short Interest
36.84%
Days to Cover
13.28

About

Sector
Health Care
Industry
Biotechnology
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improvi...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Recursion Pharmaceuticals (RXRX) stock?

A

You can purchase shares of Recursion Pharmaceuticals (NASDAQ:RXRX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Recursion Pharmaceuticals (RXRX) competitors?

A

There are no as such competitors for Recursion Pharmaceuticals.

Q

What is the forecast, or price target, for Recursion Pharmaceuticals (RXRX) stock?

A

Recursion Pharmaceuticals has a consensus price target of $10.61.

Q

What is the current price for Recursion Pharmaceuticals (RXRX)?

A

The stock price for Recursion Pharmaceuticals (NASDAQ: RXRX) is $3.61 last updated June 2, 2026 at 5:42 PM EDT.

Q

Does Recursion Pharmaceuticals (RXRX) pay a dividend?

A

There are no upcoming dividends for Recursion Pharmaceuticals.

Q

When is Recursion Pharmaceuticals (NASDAQ:RXRX) reporting earnings?

A

Recursion Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Recursion Pharmaceuticals (RXRX) going to split?

A

There is no upcoming split for Recursion Pharmaceuticals.

Q

What sector and industry does Recursion Pharmaceuticals (RXRX) operate in?

A

Recursion Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.